Annual Drug Patent Expirations for NERLYNX
Nerlynx is a drug marketed by Puma Biotech and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug.
This drug has one hundred and sixteen patent family members in twenty-nine countries.
The generic ingredient in NERLYNX is neratinib maleate. One supplier is listed for this compound. Additional details are available on the neratinib maleate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
